Cover Image
市場調查報告書

Ascepion Pharmaceuticals, Inc.:產品平台分析

Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 318936
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Ascepion Pharmaceuticals, Inc.:產品平台分析 Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 21 Pages
簡介

Ascepion Pharmaceuticals, Inc.是研發抗癌治療法的生物製藥企業。該公司的產品使用Azaindole、Pyridine、Indole、Benzene、Isonicotinic acid等化學物質。

本報告提供Ascepion Pharmaceuticals, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,以及最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Ascepion Pharmaceuticals, Inc.的基本資料

  • Ascepion Pharmaceuticals, Inc.概要
  • 主要資訊
  • 企業資料

Ascepion Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Ascepion Pharmaceuticals, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Ascepion Pharmaceuticals, Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Ascepion Pharmaceuticals, Inc.:藥物簡介

  • ASP-08112
  • ASP-08126
  • ASP-502D

Ascepion Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Ascepion Pharmaceuticals, Inc.:最近的開發平台趨勢

Ascepion Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07787CDB

Summary

Global Markets Direct's, 'Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Ascepion Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ascepion Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ascepion Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ascepion Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ascepion Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Ascepion Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ascepion Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ascepion Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ascepion Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ascepion Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ascepion Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ascepion Pharmaceuticals, Inc. Snapshot
    • Ascepion Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Ascepion Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Ascepion Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Ascepion Pharmaceuticals, Inc. - Pipeline Products Glance
    • Ascepion Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase 0 Products/Combination Treatment Modalities
    • Ascepion Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Ascepion Pharmaceuticals, Inc. - Drug Profiles
    • ASP-08126
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASP-08112
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASP-502D
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ascepion Pharmaceuticals, Inc. - Pipeline Analysis
    • Ascepion Pharmaceuticals, Inc. - Pipeline Products by Target
    • Ascepion Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Ascepion Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Ascepion Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Ascepion Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Ascepion Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ascepion Pharmaceuticals, Inc., Key Information
  • Ascepion Pharmaceuticals, Inc., Key Facts
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Ascepion Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Ascepion Pharmaceuticals, Inc. - Phase 0, 2015
  • Ascepion Pharmaceuticals, Inc. - Preclinical, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Ascepion Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Ascepion Pharmaceuticals, Inc., Other Locations

List of Figures

  • Ascepion Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Ascepion Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Ascepion Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top